| HS Code | 715760 |
| Productname | n-Butyl Alcohol Veterinary Grade API |
| Chemicalname | 1-Butanol |
| Synonyms | n-Butanol; Butan-1-ol; Propylcarbinol |
| Casnumber | 71-36-3 |
| Einecsnumber | 200-751-6 |
| Molecularformula | C4H10O |
| Molecularweight | 74.12 g/mol |
| Grade | Veterinary Grade |
| Purity | ≥99.0% |
| Appearance | Clear, colorless liquid |
| Odor | Mild alcoholic odor |
| Solubility | Soluble in water; miscible with ethanol, ether, and most organic solvents |
| Boilingpoint | 117.7 °C |
| Meltingpoint | -89.8 °C |
| Density | 0.810 g/cm3 at 20 °C |
| Refractiveindex | 1.3993 at 20 °C |
| Flashpoint | 29 °C closed cup |
| Autoignitiontemperature | 343 °C |
| Vaporpressure | 0.58 kPa at 20 °C |
| Ph | Neutral (approximately 7) |
| Storageconditions | Store in a cool, dry, well-ventilated area away from heat and ignition sources |
| Shelflife | 24 months when stored properly |
| Dosageforms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Packaging | Amber glass bottles, HDPE containers, or steel drums |
As an accredited n-Butyl Alcohol Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Supplied in 200 L HDPE drums, securely sealed and labeled, for veterinary-grade API applications: tablets, injections, capsules, powders, granules, premix, solutions. |
| Container Loading (20′ FCL) | Full 20′ FCL loading: n-Butyl Alcohol Veterinary Grade API, securely packed for tablets, injections, capsules, powders, granules, premix, and solutions. |
| Shipping | UN1120, Butanols (n-Butyl Alcohol), Class 3, PG III, Flammable Liquid. Ship in UN-approved, tightly closed containers in cool, dry, well-ventilated areas away from heat, sparks, and oxidizers. Label as flammable, include SDS, and comply with ADR/IATA/IMDG regulations for veterinary-grade API. |
| Storage | Store n-Butyl Alcohol Veterinary Grade API in a cool, dry, well-ventilated, fireproof area away from heat, sparks, open flames, and oxidizing agents. Keep containers tightly closed, upright, and clearly labeled. Protect from moisture, light, and contamination. Maintain appropriate temperature per manufacturer; use flammable-liquid cabinets. Segregate from incompatible materials and follow veterinary API/GMP requirements for tablets, injections, capsules, powders, granules, premix, and solutions. |
| Shelf Life | Shelf life is typically 24 months when stored airtight in cool, dry, well-ventilated conditions, away from heat, sparks, and flames. |
In wet granulation of veterinary tablet formulations containing moisture-labile actives, n-Butyl Alcohol Veterinary Grade (CAS 71-36-3, molecular weight 74.12 g/mol) is metered as the non-aqueous granulation liquid into a top-drive high-shear mixer at impeller tip speed 2–5 m/s. The selection follows the solvent’s surface tension of 24.6 mN/m at 20°C, compared with 72.8 mN/m for water, which improves wetting of hydrophobic veterinary API particles and enables binder deposition at lower liquid-to-solid ratios. Because the boiling point is 117.7°C and the dielectric constant is 17.8 at 20°C, the solvent dissolves non-ionic binders such as ethylcellulose and alcohol-soluble povidone grades while avoiding premature swelling of croscarmellose sodium or sodium starch glycolate. The granulation endpoint is controlled by impeller power draw and wet mass density rather than by fixed time. Drying is performed in a vacuum tray dryer at jacket temperature not exceeding 60°C and absolute pressure 13.3–26.7 kPa until loss on drying is ≤2.0%. Residual n-butanol in the dried granule is quantified by headspace gas chromatography with flame ionization detection using a DB-624 column, 30 m × 0.32 mm × 1.8 μm, split ratio 20:1, per USP <467> and VICH GL18(R2). The acceptance limit is 5000 ppm under Option 1 for Class 3 solvents unless the daily tablet dose exceeds 10 g, at which point the 50 mg/day permitted daily exposure applies. Compression of the dried granule is run on a rotary tablet press with precompression force 3–8 kN and main compression force 10–25 kN, target tablet hardness 60–120 N. Hardness is measured by a calibrated hardness tester with 10 N resolution. The use of n-butanol rather than water suppresses hydrolysis of actives during massing, but it requires explosion-rated material handling because the flash point is 35°C closed cup.
The porosity-regulating effect follows from the low water activity and the surface tension gradient generated when 5–15 wt% n-butanol is blended into the wet mass. In water-granulated controls, capillary forces during drying collapse pore throats and increase granule densification. With n-butanol, the solvent evaporates from the granule surface at a slower rate than water while forming a heterogeneous azeotrope at 92.7°C with a water content of approximately 42.5 wt%, thereby stripping residual water introduced by binder solutions or raw materials. This azeotropic removal is used in a vacuum distillation cycle attached to the dryer condenser, not in the granulator itself. The resulting dried granules can show higher intragranular porosity and lower apparent bulk density than water-granulated material, but the magnitude is formulation-dependent and published data for a specific veterinary formulation is limited. Mercury intrusion porosimetry of dried granules can record modal pore diameters in the 2–10 μm range, yet this range must be generated for each batch because the pore architecture is sensitive to massing time and solvent load. Binder migration during drying is reduced because n-butanol has a dielectric constant of 17.8, which weakens electrostatic attraction between charged API surfaces and binder polymers. The process boundary is narrow: residual water above 5 wt% in the solvent recycle loop lowers the azeotrope stripping capacity and extends drying time beyond 8 h at 50°C jacket temperature. Operators monitor water content in the recovered solvent by Karl Fischer titration at ≤0.5 wt% before reuse. The granule porosity profile directly influences tablet disintegration time; tablets produced from n-butanol-granulated material should be confirmed for disintegration below 15 min in pH 6.8 phosphate buffer at 37°C when evaluated per USP <701> or Ph. Eur. 2.9.1.
For parenteral veterinary APIs with poor aqueous solubility, n-Butyl Alcohol Veterinary Grade is applied in upstream recrystallization and salt formation, not as a direct injection vehicle. The solvent dissolves the free base or free acid at 50–80°C, after which sterile-filtered aqueous acid or base is added under controlled agitation to precipitate the salt. The wet cake is washed with water for injection and vacuum-dried at 40–50°C under 20–30 kPa. The final sterile powder must meet VICH GL18(R2) residual solvent criteria for Class 3 solvents; the Option 1 limit is 5000 ppm, and the permitted daily exposure is 50 mg/day where the daily dose exceeds 10 g. Because n-butanol has a log P of 0.84 and a water solubility of 77 g/L at 20°C, multiple water washes reduce residual solvent below the threshold but also extract a portion of small polar API molecules. This partition loss is calculable from the measured distribution ratio and must be included in the mass balance. The recrystallization vessel is constructed from 316L stainless steel, and the jacket is heated with tempered water rather than direct steam to avoid local hot spots above 80°C. n-Butanol is not recommended for final injectable formulations because the alcohol group produces local tissue irritation, and the material is not included in common parenteral co-solvent compendial monographs. For lyophilized veterinary injections, residual solvent is retested after freeze-drying; the lyophilizer chamber is vented through a condenser at −60°C and a carbon adsorption bed to recover solvent vapors. Particle size of the recrystallized API is controlled by addition rate and agitation, with particle size distribution measured by laser diffraction per ISO 13320:2020.
Hard gelatin and hydroxypropylmethylcellulose capsule shells used for veterinary medicines contain defined moisture levels that influence shell rupture and fill compatibility. Hard gelatin shells typically hold 13–16% moisture, while HPMC shells hold 2–8%. n-Butyl Alcohol Veterinary Grade is used as a manufacturing solvent for liquid-fill capsule formulations only after shell compatibility screening under 40°C/75% RH for 6 months per VICH GL3(R). The fill mass may contain n-butanol at low concentration as a processing solvent for lipid or non-aqueous excipient systems, but residual n-butanol must remain within the 5000 ppm limit in the total capsule fill. Migration of n-butanol from the fill into the gelatin shell occurs because the solvent has a water solubility of 77 g/L at 20°C; the migration rate increases with fill water activity and storage temperature. Shell tensile strength is measured by a texture analyzer with a 2 mm diameter stainless steel probe, and shell rupture force must maintain the manufacturer's specification for automatic capsule-filling machines, commonly not less than 1.5 N for hard gelatin capsules. Published compatibility data for n-butanol in specific veterinary capsule formulations is limited; therefore, shell evaluation should include weight gain, brittleness, and dissolution performance per USP <711> or Ph. Eur. 2.9.3. The use of n-butanol in liquid-fill capsules is constrained by its flash point of 35°C; filling lines require local exhaust ventilation and electrical classification matched to solvent vapour zones.
| Dosage form | Processing stage | Residual solvent limit | Primary standard | Analytical method |
|---|---|---|---|---|
| Tablet/granule | Wet granulation drying | ≤5000 ppm | USP <467>, VICH GL18(R2) | Headspace GC-FID |
| Injection | Upstream recrystallization or lyophilization | ≤5000 ppm or 50 mg/day if dose > 10 g | VICH GL18(R2) | Headspace GC-MS |
| Premix | Spray adsorption onto feed carrier | ≤5000 ppm | USP <467> | Headspace GC-FID |
| Oral solution | Vacuum distillation or retained cosolvent | ≤5000 ppm | Ph. Eur. 5.4, VICH GL18(R2) | Headspace GC-FID |
In medicated premix production, n-Butyl Alcohol Veterinary Grade is sprayed onto a feed-grade carrier such as calcium carbonate, lactose monohydrate, or wheat middlings inside a ribbon blender equipped with a twin-fluid nozzle. The spray rate and atomizing air pressure are adjusted to achieve uniform solvent distribution without carrier clumping; typical atomizing air pressure is 0.15–0.30 MPa and batch temperature is kept below 30°C. After blending for 10–15 min, the premix is discharged into a vacuum dryer and residual n-butanol is reduced to ≤5000 ppm per VICH GL18(R2). Because n-butanol is a Class 3 solvent, this limit applies without additional justification. The dried premix is milled through a 1.0 mm screen before addition to feed. Dust control is achieved by the solvent carrier acting as a temporary agglomerating agent; after drying, the premix particle size distribution is measured by sieve analysis per ISO 3310-1:2016.
Coating of veterinary powders with n-butanol solutions imposes a closed-loop solvent recovery system because the flash point is 35°C closed cup and the lower explosive limit is 1.4 vol% in air. The solution is sprayed in a fluid-bed coater at inlet air temperature 40–55°C, inlet air dew point ≤0°C, and spray rate controlled to maintain product temperature at 25–30°C. Exhaust vapour passes through a chilled condenser at −5°C and a carbon adsorption bed; the recovered n-butanol is tested for water content by Karl Fischer titration at ≤0.5 wt% before reuse. Coating polymers such as ethylcellulose or methacrylic acid copolymers are dissolved at 5–15% solids in n-butanol-isopropanol mixtures. The use of n-butanol increases the coating solution surface tension window and reduces viscosity compared with pure ethanol, which improves atomization through a 0.8 mm two-fluid nozzle. The lower explosive limit imposes a maximum solvent vapour concentration of 25% LEL in the process air, typically 0.35 vol% for n-butanol, monitored by infrared gas detection. Processing is paused automatically if vapour concentration exceeds 40% LEL. The final coated powder must have residual n-butanol below 5000 ppm per USP <467> and moisture content not exceeding 3.0% by Karl Fischer titration.
Oral drench solutions and concentrated veterinary liquids are manufactured by dissolving the active pharmaceutical ingredient in n-Butyl Alcohol Veterinary Grade at elevated temperature before dilution with purified water or buffer. The solvent is removed by vacuum distillation at 40–50°C and 20–30 kPa absolute pressure in a glass-lined reactor. The final solution is filtered through a 0.45 μm polyvinylidene fluoride membrane and checked for clarity per Ph. Eur. 2.2.1. Residual n-butanol is controlled to ≤5000 ppm per VICH GL18(R2), or 50 mg/day if the daily oral dose exceeds 10 g. For thermolabile veterinary actives that cannot tolerate distillation, n-butanol remains in the final solution at the Class 3 limit and is included in the product specification. The solvent is not used with oxidizing agents such as hydrogen peroxide or sodium hypochlorite in standard sanitization sequences because the alcohol group can be oxidized to butyric acid, shifting pH and producing off-odour. The oral solution must be packaged in high-density polyethylene or glass bottles with closures that have low vapour transmission to prevent solvent loss and moisture gain during stability storage at 30°C/65% RH for 24 months per VICH GL3(R).
Competitive n-Butyl Alcohol Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618963613625 or mail to sales10@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8618963613625
Email: sales10@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
n-Butyl Alcohol (butan-1-ol, CAS 71-36-3, molecular mass 74.12 g·mol⁻¹) supplied as a veterinary-grade API for tablet, injection, capsule, powder, granule, premix, and solution processing is a clear, low-volatility primary alcohol manufactured either by propylene oxo synthesis or via acetone-butanol-ethanol (ABE) fermentation with subsequent fractional distillation. The API designation in this context does not indicate a pharmacologically active veterinary substance; rather, it reflects manufacture under ICH Q7 active pharmaceutical ingredient GMP when the alcohol functions as a process-determining solvent input for downstream dosage form manufacture. Three product designations differentiate water content and intended application: NBU-VET-500-LIQ (water ≤0.05% w/w) is specified for injection and solution processing where moisture-sensitive actives are present; NBU-VET-2000-GR (water ≤0.20% w/w) is designated for non-aqueous wet granulation where controlled moisture assists polymeric binder activation; and NBU-VET-5000-PM (water ≤0.50% w/w) is designated for powder, premix, and granule carrier processes where higher ambient humidity tolerance is required. The liquid has a boiling point of 117.7°C, a flash point of 35°C (closed cup), a lower flammability limit of 1.4% v/v, and an autoignition temperature of 343°C. NFPA 704 ratings are health 1, flammability 3, reactivity 0. Water solubility is 77 g/L at 20°C, and the n-butanol-water minimum boiling azeotrope at 92.7°C contains 42.5% water.
Release testing follows USP general chapters <841> Specific Gravity, <831> Refractive Index, <921> Water Determination Method Ic, and <467> Residual Solvents. Assay is performed by gas chromatography with flame ionization detection (GC-FID) using a compendial butyl alcohol reference standard, with area normalization for related substances including isobutyl alcohol, sec-butyl alcohol, butyraldehyde, and dibutyl ether. Elemental impurities are controlled per USP <232>/<233> and ICH Q3D for oral veterinary products. Unlike reagent-grade n-butanol, the veterinary API grade is subject to change control and lot-to-lot consistency requirements under ICH Q7, including stability data generated at 25°C/60% RH and 40°C/75% RH in the intended container closure system. Table 1 summarizes release parameters.
| Parameter | Method | Specification |
|---|---|---|
| Assay (C4H10O) | GC-FID | ≥99.5% w/w |
| Water | USP <921> Method Ic | ≤0.05% w/w (NBU-VET-500-LIQ) |
| Specific gravity | USP <841> at 20°C | 0.807–0.810 |
| Refractive index | USP <831> at 20°C | 1.398–1.399 |
| Nonvolatile residue | Evaporation at 105°C | ≤0.005% w/w |
| Residual solvents | USP <467> Option 2 | Conforms to ICH Q3C Class 3 |
| Elemental impurities | USP <232>/<233> | Conforms to ICH Q3D for oral veterinary products |
Residual n-butanol in finished veterinary dosage forms is controlled under VICH GL18, which mirrors the ICH Q3C solvent classification. Because n-butanol is a Class 3 solvent with a permitted daily exposure of 50 mg/day, finished tablets, capsules, powders, granules, premixes, and solutions may contain residual n-butanol at levels consistent with USP <467> Option 1 or Option 2. For a 20 g oral bolus administered to a 10 kg dairy cow, the Option 1 limit is 2,500 ppm (0.25% w/w), calculated as 50 mg/day ÷ 20 g/day × 106. For a 500 mg tablet administered to a 5 kg companion animal, the corresponding limit is 100,000 ppm (10% w/w), but practical drying constraints and organoleptic thresholds reduce residual n-butanol below 500 ppm in routine manufacture. Headspace GC-FID is employed for release testing with a validated range of 10–500 ppm and a limit of quantification of 10 ppm; method validation follows VICH GL2. The calculated limit is dose-dependent, not a fixed universal concentration; misuse occurs when a single ppm specification is applied across all dosage strengths without dose-based adjustment.
In high-shear wet granulation for tablets and capsules, n-butanol is typically applied at 2.5–8.0% w/w of the dry powder blend. The higher boiling point of 117.7°C and lower vapor pressure of 0.58 kPa at 20°C extend the liquid bridge persistence window relative to ethanol, reducing premature granule breakage during discharge and transfer. However, the 35°C flash point requires explosion-proof granulation suites designed to NFPA 30 and NFPA 69. A processing conflict arises in fluid-bed drying: inlet air temperatures above 55°C accelerate volatilization but promote surface crusting of the granule shell, trapping residual alcohol in the core and producing inhomogeneous residual solvent profiles. This phenomenon is more pronounced when the inlet air relative humidity exceeds 60%, requiring pre-drying of the granulator bowl and extended drying ramps at 45°C for 20–40 min. The n-butanol-water azeotrope at 92.7°C (containing 42.5% water) causes alcohol-rich vapor to be removed preferentially during early drying, leaving behind a water-enriched granule mass that can elevate final loss-on-drying values above the 0.5% w/w target. Published data for this specific azeotrope behavior in veterinary granulation is limited; the drying endpoint is therefore confirmed gravimetrically and by USP <467> headspace GC rather than by temperature alone. On continuous twin-screw wet granulators with L/D 40:1, barrel temperatures of 110–130°C combined with vacuum devolatilization at -0.08 MPa reduce residual n-butanol below 0.1% w/w, but screw speeds above 600 rpm can induce foaming at the vacuum port due to boiling point elevation from dissolved binder solids; published data for veterinary formulations in this equipment configuration is limited.
Powder and premix applications use n-butanol as a liquid carrier for fat-soluble veterinary actives, applied at 0.5–2.0 L per metric ton of corncob or rice hull carrier. Adsorption uniformity is assessed by solvent distribution coefficient and by Carr index of the loaded premix before blending into final feed. n-Butanol's limited water solubility of 77 g/L at 20°C reduces phase separation when premix is exposed to humid feed mill environments, whereas ethanol and isopropanol absorb atmospheric moisture more aggressively and can cause clumping. However, evaporation from feed premix is slow; packed premix that is sealed immediately after loading retains residual alcohol above sensory thresholds. Published drying data for n-butanol-loaded feed premix under feed mill conditions is limited; therefore, a minimum hold time of 48 h at 25°C and 60% RH is recommended before bulk shipment, with confirmation by headspace GC. For granules and powders, n-butanol is used as a binder solvent in fluid-bed top-spray granulation at 2.0–5.0% w/w, with droplet size controlled by nozzle air pressure between 0.10–0.20 MPa and liquid feed rate adjusted to maintain product temperature below 45°C. Capsule fill masses containing n-butanol-processed granules require a drying endpoint of ≤0.5% w/w loss on drying to prevent shell softening and cross-linking of gelatin capsule bodies during storage.
Selection among Class 3 solvents is governed by evaporation rate, water miscibility, binder compatibility, and residual solvent removal efficiency. n-Butanol has a relative evaporation rate of 0.46 (n-butyl acetate = 1), compared with 2.0 for ethanol and 1.7 for isopropanol. The slower evaporation rate makes n-butanol suitable for sustained binder plasticization during low-shear mixing but extends drying cycle times. Viscosity at 25°C is 2.95 mPa·s for n-butanol, 2.04 mPa·s for isopropanol, and 1.1 mPa·s for ethanol; higher viscosity alters spray nozzle droplet size distribution in film coating, producing larger droplets and potential orange-peel defects when n-butanol is substituted without nozzle parameter adjustment. Table 2 summarizes comparative solvent properties.
| Solvent | CAS | ICH Q3C Class | PDE (mg/day) | Boiling point (°C) | Water solubility (g/L at 20°C) | Relative evaporation rate (n-BuAc=1) |
|---|---|---|---|---|---|---|
| n-Butanol | 71-36-3 | Class 3 | 50 | 117.7 | 77 | 0.46 |
| Ethanol | 64-17-5 | Class 3 | 50 | 78.3 | Miscible | 2.0 |
| Isopropanol | 67-63-0 | Class 3 | 50 | 82.6 | Miscible | 1.7 |
| Acetone | 67-64-1 | Class 3 | 50 | 56.1 | Miscible | 5.6 |
| Methanol | 67-56-1 | Class 2 | 30 | 64.7 | Miscible | 3.5 |
Methanol is excluded from veterinary tablet and premix formulations not only because it is an ICH Q3C Class 2 solvent with a PDE of 30 mg/day, but also because its metabolite formaldehyde contributes to species-specific toxicity. Acetone, despite a favorable Class 3 PDE of 50 mg/day, is an aprotic solvent with a boiling point of 56.1°C that dries too rapidly for sustained binder dissolution in low-shear granulation and does not readily dissolve hydroxypropyl cellulose coatings. Isopropanol and ethanol are fully water-miscible, whereas n-butanol saturates at 77 g/L; this limited miscibility is exploited in biphasic extraction and in premix carriers where atmospheric moisture uptake must be minimized. The choice of n-butanol over isopropanol is therefore justified only when process data show unacceptable granule friability or excessive moisture adsorption with the lower-boiling alcohols; published comparative granulation studies for veterinary premix substrates are limited, so solvent substitution requires pilot-scale confirmation under the intended equipment configuration.
n-Butanol is not used as a primary injectable vehicle. Although the material is supplied as an API-grade solvent, parenteral use is confined to micro-concentrations governed by the ICH Q3C Class 3 residual solvent limit of 50 mg/day and by in vitro hemolytic screening against washed erythrocytes from the target veterinary species. The n-octanol/water partition coefficient of 0.84 and the straight-chain C4 structure place n-butanol between ethanol and n-pentanol in erythrocyte membrane fluidization propensity; a screening protocol incubates washed erythrocyte suspensions at 37°C for 60 min with n-butanol concentrations of 0.01%, 0.05%, and 0.10% v/v, comparing hemolysis to a positive control. Hemolysis exceeding 5% relative to the positive control is considered unacceptable for further parenteral development. The water solubility limit of 77 g/L at 20°C dictates that n-butanol cannot serve as a sole aqueous cosolvent above this concentration without phase separation; any hypothetical injectable formulation would require a water-miscible cosolvent such as propylene glycol and would be subject to VICH GL43 target animal safety data. Published data for intravenous tolerance of n-butanol in cattle, swine, and equine species are limited; therefore, the injectable route is not recommended unless species-specific safety qualification is completed.
Storage requires a cool, well-ventilated flammables cabinet maintained at 15–25°C, separated from strong oxidizing agents, acid chlorides, and acid anhydrides. Nitrogen blanketing is specified for drums that have been partially dispensed, because headspace oxygen promotes slow oxidation to butyraldehyde and butyric acid, which elevates titratable acidity above the compendial limit. The flash point of 35°C and lower flammability limit of 1.4% v/v require transfer operations to maintain solvent vapor below 25% of the LEL (0.35% v/v) via local exhaust ventilation. Stability data support a 24-month retest date in unopened nitrogen-blanketed HDPE containers at 15–25°C; after opening, retesting of water content and acidity is recommended at 6-month intervals. Incompatibilities include exothermic reactions with strong bases, oxidizing agents, and isocyanates. The material is classified as a flammable liquid under 49 CFR 173.120 for transport and must be labeled with the GHS02 flame pictogram.